ABSTRACT
INTRODUCTION
Hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are the three most common chronic viral pathogens of major public health concerns having similar routes of transmission, such as blood and blood products, sharing of needles to inject drugs and sexual activity) are; all of them are associated with increasing morbidity and mortality. 1, 2 The HBV and HCV infection lead to chronic liver diseases, especially cirrhosis and hepatocellular carcinoma.
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is compromised, resulting into the life-threatening infections.
Viral hepatitis B and hepatitis C are significant global health issues. It is estimated that about 2 billion people are exposed to hepatitis B worldwide, with 350 million suffering from chronic infection. Similarly, more than 200 million people are estimated to be suffering from chronic infection with hepatitis C throughout the world. Moreover, hepatitis B is estimated to result in 563,000 deaths annually versus 366,000 deaths for hepatitis C worldwide. 3 More than 30 million people around the world have died of AIDS-related diseases and around 34 million people were living with HIV/AIDS in 2010. Moreover, in 2010, 2.7 million people were newly infected with HIV, and 1.8 million people died of AIDS related causes. 4 We are entering in the new era of globalization where the geographical boundary between the countries is nonexistence and its impact on the health sector is unavoidable. Hence, the increasing global prevalence of HBV, HCV and HIV can affect the prevalence in Nepal as well. There are variable data about their study in different populations in Nepal, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] but there is a lacking of their recent, complete and valid data in Nepal; hence, we aimed to study the seroprevalence of HBV, HCV and HIV in the western region of Nepal.
METHODS:
This was a cross-sectional observational study, in which 15,791 patients, attending to Manipal Teaching Hospital, Pokhara, Nepal, were investigated for HBV, HCV and HIV from June 2013 to March 2016. Among the patients with positivity on these tests, demographic and biochemical profile were studied. The informed consent was taken from the patients and the study protocol was approved from the ethics committee of the hospital.
Demographic profile included analysis of age and sex of the patients. The age was divided into different group of less than 10 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years and equal or more than 60 years. The prevalence of HBV, HCV ad HIV in the male was compared with that in the female. In the patients with positive the test results, the history regarding the alcohol intake was taken by asking the CAGE questionnaire, and those with 2 or more than 2 score on questionnaire were considered as having significant alcohol consumption; they were also investigated for the biochemical profile, which included random blood sugar, total protein, albumin, total bilirubin, AST, ALT, ALP, blood urea, and serum creatinine.
The HBV, HCV and HIV were tested by kits HEPACARD, HCV TRI- 2 U/L, respectively. The majority of HCV was found among drug addicts using the intravenous drug use, whereas the majority of patients with HIV had a history of significant consumption of alcohol resulting into the alcoholic liver disease. Discussion:
In the previous study done in Nepal in 1990 showed the prevalence of HBsAg positivity among 2,555 healthy individuals to be 0.9% (1.5% in male, 0.5% in female). 5 In a study done among blood donors in Nepal in 2008 showed the overall seroprevalence rates of HBV and HCV were 0.82% and 0.47%, respectively. In another study done among blood donors in different parts of Nepal in 2010 showed that the prevalence of HBV was 1.2% in Banke, 0.87% in Biratnagar and 0.35% in Kaski, and that of HCV was 0.26% in Morang, 0.16% in Kaski and 0.11% in Banke. 10 Another study done in Nepal in 2013
showed the prevalence of HCV and HIV to be 0.17% and 0.71%, respectively among the blood donors. 12 Our study showed the prevalence of HBV to be 1.1%, HCV 0.3% and HIV 0.5% among 15,791 patients attending to the hospital, which is not very different from the previous studies done in Nepal although the study sample was different among those studies.
The seroprevalence of HBV, HCV and HIV was found to be 0.887%, 0.101% and 0.154%,, respectively in voluntary blood donors in a study done in Western India. 16 In other different
Indian studies, HCV seroprevalence ranged between 0.57 to 1.49%,%), [17] [18] [19] [20] [21] while the study done in Kolkata showed the HCV prevalence of (0.35%). (Kolkata), which is similar to our study (0.3%).
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The prevalence of HIV was shown to be 0.55% in1995 in New Delhi, and 0.53% in 2008 in Bhopal, which is again similar to our study (0.5%).
19,20
The African countries have reported the seroprevalence of HBV, HCV and HIV in their studies. The overall seroprevalence of HBV, HCV and HIV, among blood donors was 4.7%, 0.7% and 3.8%, respectively in Ethiopia. 23 In Nigeria, the seroprevalence of HBV, HCV and HIV, among the antenatal women were 3.4%, 2.6 and 12.4%, respectively. 24 The average prevalence of HBsAg was 3.7%, anti-HCV 0.9%, and anti-HIV 0.15% among blood donors in Tripoli. 25 Our study revealed that the prevalence of HBV, HCV and HIV was more in male than that in female with the odds ratio of 1.54 for HBV ( 95% CI 1.37 -1.72), 1.61 for HCV (95% CI 1.33 -1.95) and 1.46 for HIV (95% CI 1.22 -1.75), which was statistically significant. Hence, it could be expected that more males contracted those viruses in the western region of Nepal because of their more exposure to the blood and blood products, sharing of needles to inject drugs and sexual activity. In our study, the liver enzymes (AST and ALT) in all of HBV, HCV and HIV groups were raised. This raised liver enzymes in HBV and HCV group could be because of the chronic infection of the liver caused by the virus, whereas that in HIV group could be because of the concomitant alcoholic liver disease because majority of HIV was found among the population with the history of significant alcoholic consumption leading to the alcoholic liver disease. Moreover, majority of HCV was found among drug addicts using the intravenous drug abuse,
In order to prevent or decrease the incidence of those dreadful HBV, HCV and HIV infections, it is important to make the public aware of the risks of contracting those viruses with the exposure to the unscreened blood and blood products, sharing of needles to inject drugs and unprotected sexual activity.
Our study was not without limitations. The HBV, HCV and HIV were tested by kits HEPACARD, HCV TRI-DOT and HIV TRI-DOT, respectively; the tests were not repeated with other confirmatory tests. However, the quality of the kits were verified by internal and external evaluation which ensured the sensitivity and specificity of the tests being more than 99%.
Since this was only cross-sectional observational study, the course of the disease caused by the infection could not be followed up.
In conclusion, HBV was more prevalent followed by HIV and HCV in the western region of Nepal with more prevalence seen in males than in females. Regular screening of HBV, HCV and HIV among the selected patients can help detecting many new cases in Nepal. Moreover, as the majority of patients with HIV also had alcoholic liver disease, regular screening for HIV is advised in patients presenting with alcoholic liver disease in Nepal.
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